Failure to remit at endpoint · adults with panic disorder
1 finding from 1 review
panic symptoms · adults with panic disorder
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
TCA showed no clear difference in number of dropouts due to adverse events compared with MAOI (low certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
SSRIs showed no clear difference in failure to respond compared with MAOIs (moderate certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
SSRIs showed no clear difference in total number of dropouts compared with MAOIs (low certainty).
1 finding from 1 review
Failure to remit at endpoint · adults with panic disorder
SSRIs showed no clear difference in failure to remit compared with MAOIs (moderate certainty).
1 finding from 1 review
panic symptoms · adults with panic disorder
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
SSRIs showed no clear difference in number of dropouts due to adverse events compared with MAOIs (low certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
SSRIs showed no clear difference in failure to respond compared with SNRIs (high certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
SSRIs showed no clear difference in total number of dropouts compared with SNRIs (low certainty).
1 finding from 1 review
Failure to remit at endpoint · adults with panic disorder
SSRIs showed no clear difference in failure to remit compared with SNRIs (high certainty).
1 finding from 1 review
panic symptoms · adults with panic disorder
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
SSRIs showed no clear difference in number of dropouts due to adverse effects compared with SNRIs (low certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
1 finding from 1 review
Leaving the study early · adults with panic disorder
SSRIs showed no clear difference in total number of dropouts compared with naSSAs (low certainty).
1 finding from 1 review
Failure to remit at endpoint · adults with panic disorder
1 finding from 1 review
panic symptoms · adults with panic disorder
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
SSRIs showed no clear difference in number of dropouts due to adverse events compared with naSSAs (low certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
It is very uncertain whether TCAs changes failure to respond compared with benzodiazepines (very low certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
It is very uncertain whether TCAs changes total number of dropouts compared with benzodiazepines (very low certainty).
1 finding from 1 review